TELA Bio (TELA) Invested Capital (2018 - 2026)

TELA Bio has reported Invested Capital for 9 years, with the latest figure at $54.8 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 202.37% year-over-year to $54.8 million; the trailing twelve-month figure through Mar 2026 stood at $54.8 million (up 202.37% YoY), and the FY2025 full-year result was $66.3 million, down 3.13% from the prior year.
• Invested Capital for Q1 2026 stood at $54.8 million, down from $66.3 million in the prior quarter.
• The five-year high for Invested Capital was $68.5 million in Q4 2024, with the low at -$6.3 million in Q3 2024.
• Average Invested Capital over 5 years is $26.1 million, with a median of $18.9 million recorded in 2023.
• Year-over-year, Invested Capital jumped 2694.36% in 2023 and tumbled 120.53% in 2024.
• Tracing TELA's Invested Capital over 5 years: stood at $14.3 million in 2022, then jumped by 31.99% to $18.9 million in 2023, then jumped by 262.58% to $68.5 million in 2024, then fell by 3.13% to $66.3 million in 2025, then retreated by 17.36% to $54.8 million in 2026.
• The last three Invested Capital figures came in at $54.8 million (Q1 2026), $66.3 million (Q4 2025), and $41.6 million (Q3 2025), per Business Quant data.

Peer Comparison